Our experiments first revealed that BMPR-II (2.02 times in asthma vs. control groups), SMAD3 (2.14 times in asthma vs. control groups), and MRTF (1.45 times in asthma vs. control groups) are highly expressed in ASMCs in our asthma model. This evidence concerns the gene BMPR2 and asthma.